We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current IBIO market cap is 38.12M. The company's latest EPS is USD -2.5223 and P/E is -1.53.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 175k | 0 | 200k |
| Operating Income | -4.5M | -3.63M | -3.41M | -4.11M | -4.42M |
| Net Income | -8.21M | -3.17M | -7.78M | -3.99M | -4.36M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.64M | 2.37M | 2.38M | 0 | 225k |
| Operating Income | -14M | -31.11M | -49.69M | -29.34M | -16.63M |
| Net Income | -38.26M | -23.47M | -50.39M | -65.01M | -24.91M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 34.02M | 50.15M | 28.73M | 24.52M | 21.7M |
| Total Liabilities | 24.83M | 25.29M | 7.41M | 6.76M | 7.8M |
| Total Equity | 9.2M | 24.86M | 21.32M | 17.75M | 13.9M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 94.19M | 146.97M | 99.41M | 41.21M | 28.73M |
| Total Liabilities | 37.58M | 38.4M | 35.92M | 25.83M | 7.41M |
| Total Equity | 56.61M | 108.57M | 63.49M | 15.38M | 21.32M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.05M | -13.7M | -18.55M | -3.72M | -7.58M |
| Investing | 50k | 1.05M | 906k | 713k | 711k |
| Financing | 6.48M | 11.5M | 24.49M | -162k | -314k |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.35M | -30.06M | -37.48M | -30.44M | -18.55M |
| Investing | -1.15M | -26.48M | -5.13M | 7.01M | 906k |
| Financing | 65.19M | 78.84M | -6.13M | 2.3M | 24.49M |
| Market Cap | 38.12M |
| Price to Earnings Ratio | -1.53 |
| Price to Sales Ratio | 168.86 |
| Price to Cash Ratio | 2.68 |
| Price to Book Ratio | 1.78 |
| Dividend Yield | - |
| Shares Outstanding | 9.87M |
| Average Volume (1 week) | 329.97k |
| Average Volume (1 Month) | 300.13k |
| 52 Week Change | 206.35% |
| 52 Week High | 4.98 |
| 52 Week Low | 1.05 |
| Spread (Intraday) | 0.05 (1.28%) |
| Company Name | iBio Inc |
| Address |
251 little falls drive new york, new york 19808 |
| Website | https://www.ibioinc.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
